- Home
- ALDX vs FONR Comparison
ALDX vs FONR Comparison
Compare ALDX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALDX | FONR |
|---|---|---|
| Founded | 2004 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.1M | 119.0M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALDX | FONR |
|---|---|---|
| Price | $1.59 | $18.94 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 50.2K |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.43 | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $104,351,318.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.32 |
| Revenue Growth | N/A | ★ 1.43 |
| 52 Week Low | $1.07 | $12.14 |
| 52 Week High | $6.18 | $18.95 |
Technical Indicators
Market Signals| Indicator | ALDX | FONR |
|---|---|---|
| Relative Strength Index (RSI) | 34.77 | 79.71 |
| Support Level | $1.48 | $18.31 |
| Resistance Level | $1.89 | N/A |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 27.38 | 92.59 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.